About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer.
About Gilead’s Corporate Giving
In an effort to end the HIV/AIDS epidemic by 2030, UNAIDS launched the 90-90-90 Initiative, which outlines the goal of 90% of all individuals with HIV knowing this diagnosis, 90% of those diagnosed on treatment, and 90% of those on treatment achieving suppression of their virus. Through Gilead’s corporate giving, we support many of the advocates, healthcare professionals and nonprofit groups working tirelessly toward these goals in local communities.
In 2020, we provided more than USD $250 million in funding to organizations advancing efforts to end the HIV epidemic around the world, focusing on communities that are disproportionately impacted by HIV. In recent years, we’ve developed major initiatives in partnership with community organizations, including:
- The Gilead COMPASS® Initiative, a 10-year commitment of more than $100 million that seeks to address the HIV epidemic in the Southern United States
- HIV Age Positively®, which aims to support programs focused on improving the quality of life and health for people 50 or older living with HIV
- The TRANScend® Community Impact Fund, which supports Trans-led organizations working to improve the safety, health and wellness of the Transgender community
- RADIAN®, a partnership with the Elton John AIDS Foundation that seeks to address the alarming trends of HIV in Eastern Europe and Central Asia
Through these programs, we strive to help address the longstanding health inequities and pervasive HIV stigma that, when coupled with challenges stemming from the COVID-19 pandemic, continue to prevent communities facing the most severe socioeconomic challenges from accessing the HIV care and services they need.
Learn more about Gilead’s global corporate giving programs, including more on the Zeroing In™ program